Analytics View

Clinical Research Partners, LLC

Richmond, Virginia, United States

Medical office in Chesterfield County, Virginia

261 Wadsworth Dr, Richmond, VA 23236

(804) 308-8659

Lead Sponsor

# Trials

Clinical Trials at Clinical Research Partners, LLC

During the past decade, Clinical Research Partners, LLC conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 30 clinical trials were completed, i.e. on average, 56.6% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 19 clinical trials were completed. i.e. 73.1% of trials that started reached the finish line.

Trials List

Trail ID

Brief Title

Start Date

Completion Date

Status

Enrollment

NCT00088556

Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

2004-08-01

2009-05-01

Completed

100

NCT00678392

Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer

2008-09-03

2016-02-25

Completed

723

NCT00932451

An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

2010-01-01

2015-12-01

Completed

1,069

NCT00932893

An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

2009-09-01

2016-01-01

Completed

347

NCT00974311

Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy

2009-09-30

2017-11-02

Completed

1,199

NCT01154140

A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung

2011-01-13

2016-11-30

Completed

343

NCT01719380

Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer

2012-11-23

2019-02-12

Completed

156

NCT01740427

A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)

2013-02-22

2023-08-26

Active, not recruiting

666

Clinical Trials Sponsors and Collaborators

Out of the total clinical trials conducted in "Clinical Research Partners, LLC" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Incyte Corporation" with 5 trials sponsored, "ModernaTX, Inc." with 5 trials sponsored, "Pfizer" with 5 trials sponsored and "Janssen Research & Development, LLC" with 5 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Partners, LLC" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Covance" with 1 trials as a collaborator and "Institute for the Study of Aging (ISOA)" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

Clinical Trials Conditions at Clinical Research Partners, LLC

According to Clinical.Site data, the most researched conditions in "Clinical Research Partners, LLC" are "Atopic Dermatitis" (7 trials), "Crohn's Disease" (4 trials), "Asthma" (3 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (3 trials) and "Diabetes Mellitus, Type 2" (3 trials). Many other conditions were trialed in "Clinical Research Partners, LLC" in a lesser frequency.

Clinical Trials Intervention Types at Clinical Research Partners, LLC

Most popular intervention types in "Clinical Research Partners, LLC" are "Drug" (58 trials), "Biological" (16 trials), "Other" (13 trials), "Behavioral" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "Mifepristone" (3 trials), "Ruxolitinib cream" (3 trials), "mRNA-1273.214" (3 trials) and "Ad26.COV2.S" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Clinical Research Partners, LLC

The vast majority of trials in "Clinical Research Partners, LLC" are 70 trials for "All" genders and 4 trials for "Female" genders.

Clinical Trials Status at Clinical Research Partners, LLC

Currently, there are NaN active trials in "Clinical Research Partners, LLC". undefined are not yet recruiting, 11 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Clinical Research Partners, LLC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Partners, LLC, 4 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 2 trials that are defined as “Not Applicable".